Wein Matthew bought MGX
December 1, 2025 · Form 4 insider transaction
Wein Matthew bought 96,000 shares of Metagenomi Therapeutics, Inc. at $1.60 per share, a transaction worth $153.6K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
96,000
Price
$1.60
Total value
$153.6K
InsiderWein Matthew
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 1, 2025
Filing dateDecember 1, 2025
Shares owned after115,230
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares represent RSUs. 50% of the RSUs shall vest on December 5, 2026, with the remainder vesting on December 5, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date.